Published in J Pharmacol Exp Ther on July 14, 2005
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol (2013) 5.74
Recent developments in adenosine receptor ligands and their potential as novel drugs. Biochim Biophys Acta (2010) 1.53
Adenosine receptors and asthma. Br J Pharmacol (2008) 1.14
Understanding asthma using animal models. Allergy Asthma Immunol Res (2009) 0.99
Xanthines as adenosine receptor antagonists. Handb Exp Pharmacol (2011) 0.96
Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease. Trends Pharmacol Sci (2009) 0.95
Adenosine receptors and asthma in humans. Br J Pharmacol (2008) 0.93
Adenosine receptors and asthma. Handb Exp Pharmacol (2009) 0.93
The rabbit as a model for studying lung disease and stem cell therapy. Biomed Res Int (2013) 0.91
A2A adenosine receptor deficiency leads to impaired tracheal relaxation via NADPH oxidase pathway in allergic mice. J Pharmacol Exp Ther (2009) 0.83
Novel methylxanthine derivative-mediated anti-inflammatory effects in inflammatory bowel disease. World J Gastroenterol (2014) 0.81
Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation. Eur J Pharmacol (2006) 0.81
Reciprocal modulation of anti-IgE induced histamine release from human mast cells by A₁ and A(2B) adenosine receptors. Br J Pharmacol (2011) 0.79
A novel post-exposure medical countermeasure L-97-1 improves survival and acute lung injury following intratracheal infection with Yersinia pestis. Innate Immun (2011) 0.78
Involvement of A1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma. Am J Physiol Heart Circ Physiol (2010) 0.76
Adenosine receptors and vascular inflammation. Biochim Biophys Acta (2010) 0.75
Invited Lectures : Overviews Purinergic signalling: past, present and future. Purinergic Signal (2006) 0.75
Theophylline: new perspectives for an old drug. Am J Respir Crit Care Med (2003) 2.43
Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol (1998) 2.43
Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis (1993) 2.19
The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J Clin Invest (1990) 2.12
Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol (1983) 2.10
Bronchial responsiveness to adenosine 5'-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV(1). Am J Respir Crit Care Med (2002) 1.92
DNA antisense therapy for asthma in an animal model. Nature (1997) 1.91
Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol (1992) 1.84
Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine. Am Rev Respir Dis (1992) 1.62
Plasma adenosine concentration increases during exercise: a possible contributing factor in exercise-induced bronchoconstriction in asthma. J Allergy Clin Immunol (2002) 1.59
Use of an analog on-line computer for the evaluation of pulmonary resistance and dynamic compliance in the anesthetized dog. Arch Int Pharmacodyn Ther (1971) 1.22
Adenosine potentiates mediator release from human lung mast cells. Am Rev Respir Dis (1988) 1.21
Adenosine-induced bronchoconstriction and contraction of airway smooth muscle from allergic rabbits with late-phase airway obstruction: evidence for an inducible adenosine A1 receptor. J Pharmacol Exp Ther (1994) 1.12
Human mononuclear phagocytes express adenosine A1 receptors. A novel mechanism for differential regulation of Fc gamma receptor function. J Immunol (1993) 1.07
Adenosine, inflammation and asthma--a review. Inflamm Res (2004) 1.05
Adenosine up-regulation of the mucin gene, MUC2, in asthma. FASEB J (2004) 1.01
The protective effects of intravenous theophylline and enprofylline against histamine- and adenosine 5'-monophosphate-provoked bronchoconstriction: implications for the mechanisms of action of xanthine derivatives in asthma. Pulm Pharmacol (1989) 0.96
Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease. Eur Respir J (2002) 0.96
Characterization of adenosine receptors involved in adenosine-induced bronchoconstriction in allergic rabbits. Br J Pharmacol (1996) 0.93
Lipopolysaccharide binds to and activates A(1) adenosine receptors on human pulmonary artery endothelial cells. J Endotoxin Res (2002) 0.93
Targeting adenosine receptors: novel therapeutic targets in asthma and chronic obstructive pulmonary disease. Am J Respir Med (2002) 0.91
Regulation of G protein-coupled receptor-adenylyl cyclase responsiveness in human airway smooth muscle by exogenous and autocrine adenosine. Am J Respir Cell Mol Biol (2001) 0.91
The effect of anti-integrin monoclonal antibodies on antigen-induced pulmonary inflammation in allergic rabbits. Pulm Pharmacol Ther (2003) 0.88
Adenosine receptor-mediated bronchoconstriction and bronchial hyperresponsiveness in allergic rabbit model. Am J Physiol (1994) 0.87
Clinical potential of respirable antisense oligonucleotides (RASONs) in asthma. Am J Pharmacogenomics (2003) 0.87
Allergen sensitization and bronchial hyper-responsiveness to adenosine monophosphate in asthmatic patients. Clin Exp Allergy (2003) 0.82
Selective bronchial catheterization for the study of experimental lung damage in the rabbit. Proc Soc Exp Biol Med (1973) 0.81
Adenosine-induced bronchoconstriction in an allergic rabbit model: antagonism by theophylline aerosol. Agents Actions (1992) 0.80
Modification of allergen-induced airway obstruction and bronchial hyperresponsiveness in the allergic rabbit by theophylline aerosol. Agents Actions (1992) 0.80
The effect of dipyridamole on histamine- and adenosine-induced bronchoconstriction in normal and asthmatic subjects. Eur J Respir Dis (1985) 0.80
Selective activity of bamifylline on adenosine A1-receptors in rat brain. Pharmacol Res Commun (1987) 0.78
Physicians affected by Medicare Catastrophic Coverage Act. South Med J (1989) 2.47
Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells. Am J Physiol Lung Cell Mol Physiol (2001) 1.78
Piperacillin kinetics. Clin Pharmacol Ther (1979) 1.57
Cardiac effects of adenosine in A(2A) receptor knockout hearts: uncovering A(2B) receptors. Am J Physiol Heart Circ Physiol (2002) 1.43
Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. J Pharmacol Exp Ther (2008) 1.38
Role of A1 adenosine receptors in regulation of vascular tone. Am J Physiol Heart Circ Physiol (2004) 1.35
Targeted deletion of adenosine A(3) receptors augments adenosine-induced coronary flow in isolated mouse heart. Am J Physiol Heart Circ Physiol (2002) 1.27
Targeted deletion of A2A adenosine receptors attenuates the protective effects of myocardial postconditioning. Am J Physiol Heart Circ Physiol (2007) 1.17
Evidence for the involvement of nitric oxide in A2B receptor-mediated vasorelaxation of mouse aorta. Am J Physiol Heart Circ Physiol (2006) 1.16
Chest pain and ST-segment elevation 3 minutes after completion of adenosine pharmacologic stress testing. J Nucl Cardiol (2004) 1.12
Isolation and characterization of coronary endothelial and smooth muscle cells from A1 adenosine receptor-knockout mice. Am J Physiol Heart Circ Physiol (2005) 1.11
Up-regulation of A 2B adenosine receptor in A 2A adenosine receptor knockout mouse coronary artery. J Mol Cell Cardiol (2008) 1.10
Endogenous adenosine increases coronary flow by activation of both A2A and A2B receptors in mice. J Cardiovasc Pharmacol (2003) 1.09
Comparison of the vascular effects of adenosine in isolated mouse heart and aorta. Am J Physiol Heart Circ Physiol (2002) 1.08
Medicare and MAAC. South Med J (1990) 1.07
A gait-powered autologous battery charging system for artificial organs. ASAIO J (1996) 1.06
Complications following accidental administration of 1.5% glycine intravenously. Acta Anaesthesiol Scand (2008) 1.06
Role of A1 adenosine receptor in the regulation of coronary flow. Am J Physiol Heart Circ Physiol (2006) 1.04
Role of CYP epoxygenases in A2A AR-mediated relaxation using A2A AR-null and wild-type mice. Am J Physiol Heart Circ Physiol (2008) 1.03
Characterization of adenosine receptor(s) involved in adenosine-induced bronchoconstriction in an allergic mouse model. Am J Physiol Lung Cell Mol Physiol (2003) 1.02
Effects of targeted deletion of A1 adenosine receptors on postischemic cardiac function and expression of adenosine receptor subtypes. Am J Physiol Heart Circ Physiol (2006) 1.02
Intrathecal human tetanus immunoglobulin in early tetanus. Lancet (1980) 1.01
Interactions between A(2A) adenosine receptors, hydrogen peroxide, and KATP channels in coronary reactive hyperemia. Am J Physiol Heart Circ Physiol (2013) 1.00
A(1) adenosine receptor-mediated PKC and p42/p44 MAPK signaling in mouse coronary artery smooth muscle cells. Am J Physiol Heart Circ Physiol (2009) 0.99
Contributions of A2A and A2B adenosine receptors in coronary flow responses in relation to the KATP channel using A2B and A2A/2B double-knockout mice. Am J Physiol Heart Circ Physiol (2011) 0.98
Absence of adenosine-mediated aortic relaxation in A(2A) adenosine receptor knockout mice. Am J Physiol Heart Circ Physiol (2009) 0.97
A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibe. Clin Ther (2001) 0.95
Src tyrosine kinase alters gating of hyperpolarization-activated HCN4 pacemaker channel through Tyr531. Am J Physiol Cell Physiol (2007) 0.95
Fatal meningococcaemia due to group W135 amongst Haj pilgrims: implications for future vaccination policy. Ann Trop Med Parasitol (1995) 0.95
High-salt diet enhances mouse aortic relaxation through adenosine A2A receptor via CYP epoxygenases. Am J Physiol Regul Integr Comp Physiol (2008) 0.95
Involvement of COX-1 in A3 adenosine receptor-mediated contraction through endothelium in mice aorta. Am J Physiol Heart Circ Physiol (2007) 0.94
Adenosine receptors and asthma. Handb Exp Pharmacol (2009) 0.93
Role of ω-hydroxylase in adenosine-mediated aortic response through MAP kinase using A2A-receptor knockout mice. Am J Physiol Regul Integr Comp Physiol (2011) 0.92
Surfactant Protein A: regulation of innate and adaptive immune responses in lung inflammation. Am J Respir Cell Mol Biol (2001) 0.91
Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidine. Br J Clin Pharmacol (2000) 0.89
A review of recent experiments on step-to-step "hand-off" of the DNA intermediates in mammalian base excision repair pathways. Mol Biol (Mosk) (2011) 0.88
Acute ethanol/cannabinoid-induced ataxia and its antagonism by oral/systemic/intracerebellar A1 adenosine receptor antisense in mice. Brain Res (2002) 0.88
NADPH oxidase pathway is involved in aortic contraction induced by A3 adenosine receptor in mice. J Pharmacol Exp Ther (2011) 0.87
Disposition and pharmacokinetics of temozolomide in rat. Xenobiotica (2004) 0.87
Involvement of p38-mitogen-activated protein kinase in adenosine receptor-mediated relaxation of coronary artery. Am J Physiol Heart Circ Physiol (2005) 0.87
Functional and RNA expression profile of adenosine receptor subtypes in mouse mesenteric arteries. J Cardiovasc Pharmacol (2013) 0.87
Aging and estrogen alter endothelial reactivity to reactive oxygen species in coronary arterioles. Am J Physiol Heart Circ Physiol (2011) 0.86
Adenosine A1 receptors link to smooth muscle contraction via CYP4a, protein kinase C-α, and ERK1/2. J Cardiovasc Pharmacol (2013) 0.86
Micromechanical devices for intravascular drug delivery. J Pharm Sci (1998) 0.86
Involvement of mast cells in adenosine-mediated bronchoconstriction and inflammation in an allergic mouse model. J Pharmacol Exp Ther (2004) 0.86
A1 adenosine receptor negatively modulates coronary reactive hyperemia via counteracting A2A-mediated H2O2 production and KATP opening in isolated mouse hearts. Am J Physiol Heart Circ Physiol (2013) 0.85
Protein kinase C isoforms and A1 adenosine receptors in porcine coronary smooth muscle cells. Vascul Pharmacol (2002) 0.84
Genetic variants in interferon gamma (IFN-γ) gene are associated with resistance against ticks in Bos taurus and Bos indicus. Mol Biol Rep (2011) 0.84
Adenosine-mediated alteration of vascular reactivity and inflammation in a murine model of asthma. Am J Physiol Heart Circ Physiol (2008) 0.83
Population pharmacokinetics of temozolomide in cancer patients. Pharm Res (2000) 0.83
Adenosine-mediated bronchoconstriction and lung inflammation in an allergic mouse model. Pulm Pharmacol Ther (2002) 0.83
Differences in the expression of the adenosine A1 receptor in adipose tissue of obese black and white women. J Clin Endocrinol Metab (2006) 0.83
Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ. Am J Physiol Regul Integr Comp Physiol (2012) 0.82
Mechanisms of delayed preconditioning with A1 adenosine receptor activation in porcine coronary smooth muscle cells. Pol J Pharmacol (2003) 0.82
Pharmacokinetics of mitoxantrone in man and laboratory animals. Drug Metab Rev (1986) 0.82
Meningococcal infection among pilgrims visiting Madinah Al-Munawarah despite prior A-C vaccination. J Pak Med Assoc (2000) 0.81
Ischemic and pharmacological preconditioning induces further delayed protection in transgenic mouse cardiac myocytes over-expressing adenosine A1 receptors (A1AR): role of A1AR, iNOS and K(ATP) channels. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.81
Effect of potassium chloride supplementation in drinking water on broiler performance under heat stress conditions. Poult Sci (2008) 0.81
Adenosine receptors in health and disease. Preface. Handb Exp Pharmacol (2009) 0.81
Identification of a novel mutation (p.Ile198Thr) in gene TYR in a Pakistani family with nonsyndromic oculocutaneous albinism. Clin Exp Dermatol (2014) 0.81
Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation. Eur J Pharmacol (2006) 0.81
Evidence for the involvement of NADPH oxidase in adenosine receptors-mediated control of coronary flow using A1 and A3 knockout mice. Physiol Rep (2013) 0.80
High salt diet modulates vascular response in A2AAR (+/+) and A 2AAR (-/-) mice: role of sEH, PPARγ, and K ATP channels. Mol Cell Biochem (2015) 0.80
Prion protein gene polymorphisms in four goat breeds of Pakistan. Mol Biol Rep (2007) 0.80
A(2A) adenosine receptor-mediated increase in coronary flow in hyperlipidemic APOE-knockout mice. J Exp Pharmacol (2011) 0.80
Frequencies of PrP genotypes and their implication for breeding against scrapie susceptibility in nine Pakistani sheep breeds. Mol Biol Rep (2008) 0.79
Genetic variability at seven codons of the prion protein gene in nine Pakistani sheep breeds. J Genet (2008) 0.79
The adenosine A₂A receptor - myocardial protectant and coronary target in endotoxemia. Int J Cardiol (2011) 0.78
Pharmacokinetics of piperacillin and gentamicin following intravenous administration to dogs. J Pharm Sci (1983) 0.78
High-resolution vascular tissue characterization in mice using 55MHz ultrasound hybrid imaging. Ultrasonics (2012) 0.78
Performance of Bailer's method for AUC confidence intervals from sparse non-normally distributed drug concentrations in toxicokinetic studies. Pharm Res (1996) 0.77
Effects of alveolar surfactant aggregates on T-lymphocyte proliferation. Biochim Biophys Acta (2001) 0.77
Involvement of NADPH oxidase in A2A adenosine receptor-mediated increase in coronary flow in isolated mouse hearts. Purinergic Signal (2015) 0.77
P2X purinoceptors in the feline pulmonary vascular bed: distribution and selective in vivo pharmacological probes. Am J Physiol (1996) 0.77
Plasma naltrexone kinetics after intravenous bolus administration in dogs and monkeys. J Pharm Sci (1979) 0.77
A₁ adenosine receptor deficiency or inhibition reduces atherosclerotic lesions in apolipoprotein E deficient mice. Cardiovasc Res (2014) 0.77
Characterization of AUCs from sparsely sampled populations in toxicology studies. Pharm Res (1996) 0.76
Involvement of A1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma. Am J Physiol Heart Circ Physiol (2010) 0.76
Mucormycosis in a diabetic. Postgrad Med J (1982) 0.75
The relevance of lymphoid cell migration to immunodeficiency syndromes. Lymphology (1990) 0.75
Capillary gas chromatographic-mass spectrometric analysis of 15-deoxy-16-hydroxy-16-vinylprostaglandin E2. J Pharm Sci (1985) 0.75
Disposition of cefixime in the pregnant and lactating rat. Transfer to the fetus and nursing pup. Drug Metab Dispos (1988) 0.75
Pharmacokinetics of loratadine and pseudoephedrine following single and multiple doses of once- versus twice-daily combination tablet formulations in healthy adult males. Clin Ther (1997) 0.75
The contribution of donkeys to human health. Equine Vet J (2014) 0.75
Hospital pharmacy services turnover is among highest of all health professions. Hosp Pharm (1995) 0.75
Nevirapine-induced hepatitis treated with corticosteroids? AIDS (1998) 0.75
Multimedia training in nursing education. Comput Nurs (1995) 0.75
Radiation induced ovarian pathogenesis in the progeny of x-irradiated female mice. Indian J Exp Biol (1977) 0.75
Less tongue engorgement with lateral placement of the Esophageal Tracheal Combitube. Acta Anaesthesiol Scand (2008) 0.75
Pharmacodynamics and pharmacokinetics of the methyl ester of 15-deoxy-16-hydroxy-16-vinylprostaglandin E2. J Pharm Sci (1985) 0.75
Dose-dependent pharmacokinetics of a new oral cephalosporin, cefixime, in the dog. Pharm Res (1987) 0.75
Chronic ethanol feeding potentiates alpha1-adrenoceptor responsiveness in SHR aortas. Clin Exp Hypertens (2003) 0.75
Effects of adenosine analogs on inositol 1,4,5-trisphosphate production in porcine coronary artery. Vascul Pharmacol (2002) 0.75
Three-dimensional uniform grid modeling of electrical defibrillation on a data parallel computer. Comput Biol Med (1995) 0.75
High-voltage paper electrophoresis for characterization of drug metabolites. J Pharm Sci (1973) 0.75
Electrical defibrillation optimization: an automated, iterative parallel finite-element approach. IEEE Trans Biomed Eng (1997) 0.75
Managed care influences physician/hospital organization growth. Hosp Pharm (1995) 0.75
Noncompartmental determination of the absorption rate constant. J Pharm Sci (1986) 0.75
Binding of bilirubin with albumin-coupled liposomes: implications in the treatment of jaundice. Biochim Biophys Acta (2002) 0.75
Stent-based gene therapy. J Long Term Eff Med Implants (2000) 0.75